Found: 47
Select item for more details and to access through your institution.
Impaired Lipoprotein Receptor-Mediated Peripheral Binding of Plasma Amyloid-β is an Early Biomarker for Mild Cognitive Impairment Preceding Alzheimer's Disease.
- Published in:
- Journal of Alzheimer's Disease, 2011, v. 24, n. 1, p. 25, doi. 10.3233/JAD-2010-101248
- By:
- Publication type:
- Article
Impaired lipoprotein receptor-mediated peripheral binding of plasma amyloid-β is an early biomarker for mild cognitive impairment preceding Alzheimer's disease.
- Published in:
- 2011
- By:
- Publication type:
- journal article
On the intersection between systemic infection, brain vascular dysfunction and dementia.
- Published in:
- 2021
- By:
- Publication type:
- journal article
Tau pathology is associated with neuropsychiatric symptoms in a cohort of individuals of predominantly Mexican descent at risk for autosomal‐dominant Alzheimer's disease.
- Published in:
- Alzheimer's & Dementia: The Journal of the Alzheimer's Association, 2023, v. 19, p. 1, doi. 10.1002/alz.076008
- By:
- Publication type:
- Article
The Prevalence of Leg Spasticity and it's Clinical Correlates among a Cohort of persons carrying ADAD mutations.
- Published in:
- Alzheimer's & Dementia: The Journal of the Alzheimer's Association, 2023, v. 19, p. 1, doi. 10.1002/alz.075410
- By:
- Publication type:
- Article
Tau pathology is associated with neuropsychiatric symptoms in a cohort of individuals of predominantly Mexican descent at risk for autosomal‐dominant Alzheimer's disease.
- Published in:
- Alzheimer's & Dementia: The Journal of the Alzheimer's Association, 2023, v. 19, n. 10, p. 1, doi. 10.1002/alz.081700
- By:
- Publication type:
- Article
Functional hyperconnectivity is associated with higher levels of sPDGFRβ, a marker of blood brain barrier breakdown, in older adults.
- Published in:
- Alzheimer's & Dementia: The Journal of the Alzheimer's Association, 2023, v. 19, p. 1, doi. 10.1002/alz.060710
- By:
- Publication type:
- Article
Validation and utility of plasma neurofilament light as a biomarker for vascular cognitive impairment.
- Published in:
- Alzheimer's & Dementia: The Journal of the Alzheimer's Association, 2022, v. 18, n. 6, p. 1, doi. 10.1002/alz.065811
- By:
- Publication type:
- Article
The regional relationship between CSF VEGF and white matter microstructural integrity in older adults: A voxelwise DTI study.
- Published in:
- Alzheimer's & Dementia: The Journal of the Alzheimer's Association, 2022, v. 18, n. 4, p. 1, doi. 10.1002/alz.066976
- By:
- Publication type:
- Article
Subiculum fiber degeneration within the fornix white matter tract in 5xFAD mice.
- Published in:
- Alzheimer's & Dementia: The Journal of the Alzheimer's Association, 2022, v. 18, n. 3, p. 1, doi. 10.1002/alz.065987
- By:
- Publication type:
- Article
Functional hyperconnectivity is associated with higher levels of sPDGFRβ, a marker of blood brain barrier breakdown, in older adults.
- Published in:
- Alzheimer's & Dementia: The Journal of the Alzheimer's Association, 2022, v. 18, p. 1, doi. 10.1002/alz.060725
- By:
- Publication type:
- Article
Urine dicarboxylic acids are metabolic biomarkers of early Alzheimer's disease.
- Published in:
- Alzheimer's & Dementia: The Journal of the Alzheimer's Association, 2021, v. 17, p. 1, doi. 10.1002/alz.056655
- By:
- Publication type:
- Article
The relationship between blood‐brain barrier permeability and cerebral blood flow in cognitive impairment.
- Published in:
- Alzheimer's & Dementia: The Journal of the Alzheimer's Association, 2021, v. 17, p. 1, doi. 10.1002/alz.056255
- By:
- Publication type:
- Article
Relationships between cerebrovascular health and tau PET uptake are associated with global cognition: Neuroimaging / multi‐modal comparisons.
- Published in:
- Alzheimer's & Dementia: The Journal of the Alzheimer's Association, 2020, v. 16, n. 11, p. 1, doi. 10.1002/alz.045326
- By:
- Publication type:
- Article
A novel sensitive assay for detection of a biomarker of pericyte injury in cerebrospinal fluid.
- Published in:
- Alzheimer's & Dementia: The Journal of the Alzheimer's Association, 2020, v. 16, n. 6, p. 821, doi. 10.1002/alz.12061
- By:
- Publication type:
- Article
P2‐385: BRAIN IMAGING OF VASCULAR DYSFUNCTION AS AN EARLY BIOMARKER OF COGNITIVE DECLINE.
- Published in:
- Alzheimer's & Dementia: The Journal of the Alzheimer's Association, 2019, v. 15, p. P751, doi. 10.1016/j.jalz.2019.06.2792
- By:
- Publication type:
- Article
P2‐101: CSF INTERLEUKIN‐8, A KEY SIGNALING FACTOR FOR INFLAMMATION, IS ASSOCIATED WITH FUNCTIONAL CONNECTIVITY AND EXECUTIVE FUNCTION.
- Published in:
- Alzheimer's & Dementia: The Journal of the Alzheimer's Association, 2019, v. 15, p. P611, doi. 10.1016/j.jalz.2019.06.2508
- By:
- Publication type:
- Article
P2‐057: 3K3A‐ACTIVATED PROTEIN C BLOCKS AMYLOIDOGENIC BACE1 PATHWAY AND IMPROVES FUNCTIONAL OUTCOME IN MICE.
- Published in:
- Alzheimer's & Dementia: The Journal of the Alzheimer's Association, 2019, v. 15, p. P593, doi. 10.1016/j.jalz.2019.06.2464
- By:
- Publication type:
- Article
P1‐034: UPREGULATION OF ENDOTHELIAL PICALM EXPRESSION USING AN FDA‐APPROVED DRUG REDUCES AMYLOID‐β LOAD IN THE MURINE BRAIN.
- Published in:
- Alzheimer's & Dementia: The Journal of the Alzheimer's Association, 2019, v. 15, p. P245, doi. 10.1016/j.jalz.2019.06.059
- By:
- Publication type:
- Article
P1‐006: A NOVEL ASSAY FOR A BIOMARKER OF PERICYTE INJURY IN HUMAN CEREBROSPINAL FLUID.
- Published in:
- Alzheimer's & Dementia: The Journal of the Alzheimer's Association, 2019, v. 15, p. P231, doi. 10.1016/j.jalz.2019.06.031
- By:
- Publication type:
- Article
Vascular dysfunction—The disregarded partner of Alzheimer's disease.
- Published in:
- Alzheimer's & Dementia: The Journal of the Alzheimer's Association, 2019, v. 15, n. 1, p. 158, doi. 10.1016/j.jalz.2018.07.222
- By:
- Publication type:
- Article
A multimodal RAGE-specific inhibitor reduces amyloid β-mediated brain disorder in a mouse model of Alzheimer disease.
- Published in:
- 2012
- By:
- Publication type:
- journal article
A multimodal RAGE-specific inhibitor reduces amyloid β–mediated brain disorder in a mouse model of Alzheimer disease.
- Published in:
- Journal of Clinical Investigation, 2012, v. 122, n. 4, p. 1377, doi. 10.1172/JCI58642
- By:
- Publication type:
- Article
Impaired vascular-mediated clearance of brain amyloid beta in Alzheimer's disease: The role, regulation and restoration of LRP1.
- Published in:
- Frontiers in Aging Neuroscience, 2015, p. 1, doi. 10.3389/fnagi.2015.00136
- By:
- Publication type:
- Article
Author Correction: Pericyte loss influences Alzheimer-like neurodegeneration in mice.
- Published in:
- 2023
- By:
- Publication type:
- Correction Notice
From the liver to the blood-brain barrier: An interconnected system regulating brain amyloid-β levels.
- Published in:
- Journal of Neuroscience Research, 2011, v. 89, n. 7, p. 967, doi. 10.1002/jnr.22670
- By:
- Publication type:
- Article
Cerebrospinal fluid biomarkers of neurovascular dysfunction in mild dementia and Alzheimer's disease.
- Published in:
- Journal of Cerebral Blood Flow & Metabolism, 2015, v. 35, n. 7, p. 1055, doi. 10.1038/jcbfm.2015.76
- By:
- Publication type:
- Article
Endothelial protein C receptor-assisted transport of activated protein C across the mouse blood–brain barrier.
- Published in:
- Journal of Cerebral Blood Flow & Metabolism, 2009, v. 29, n. 1, p. 25, doi. 10.1038/jcbfm.2008.117
- By:
- Publication type:
- Article
Transport pathways for clearance of human Alzheimer's amyloid β-peptide and apolipoproteins E and J in the mouse central nervous system.
- Published in:
- Journal of Cerebral Blood Flow & Metabolism, 2007, v. 27, n. 5, p. 909, doi. 10.1038/sj.jcbfm.9600419
- By:
- Publication type:
- Article
Relationship Between Cyclophilin A Levels and Matrix Metalloproteinase 9 Activity in Cerebrospinal Fluid of Cognitively Normal Apolipoprotein E4 Carriers and Blood-Brain Barrier Breakdown.
- Published in:
- JAMA Neurology, 2013, v. 70, n. 9, p. 1198, doi. 10.1001/jamaneurol.2013.3841
- By:
- Publication type:
- Article
Correction: Retinal nerve fiber layer thickness predicts CSF amyloid/tau before cognitive decline.
- Published in:
- 2020
- By:
- Publication type:
- Correction Notice
Retinal nerve fiber layer thickness predicts CSF amyloid/tau before cognitive decline.
- Published in:
- PLoS ONE, 2020, v. 15, n. 5, p. 1, doi. 10.1371/journal.pone.0232785
- By:
- Publication type:
- Article
Impaired vascular-mediated clearance of brain amyloid beta in Alzheimer's disease: The role, regulation and restoration of LRP1.
- Published in:
- Frontiers in Neuroscience, 2015, p. 1, doi. 10.3389/fnagi.2015.00136
- By:
- Publication type:
- Article
Pericyte loss influences Alzheimer-like neurodegeneration in mice.
- Published in:
- Nature Communications, 2013, v. 4, n. 1, p. 1, doi. 10.1038/ncomms3932
- By:
- Publication type:
- Article
Pericyte loss influences Alzheimer-like neurodegeneration in mice.
- Published in:
- Nature Communications, 2013, v. 4, n. 12, p. 2932, doi. 10.1038/ncomms3932
- By:
- Publication type:
- Article
The Pericyte: A Forgotten Cell Type with Important Implications for Alzheimer's Disease?
- Published in:
- Brain Pathology, 2014, v. 24, n. 4, p. 371, doi. 10.1111/bpa.12152
- By:
- Publication type:
- Article
Low-density lipoprotein receptor-related protein-1: a serial clearance homeostatic mechanism controlling Alzheimer's amyloid β-peptide elimination from the brain B. V. Zlokovic et al. LRP1: a key regulator of Aβ homeostasis.
- Published in:
- Journal of Neurochemistry, 2010, v. 115, n. 5, p. 1077, doi. 10.1111/j.1471-4159.2010.07002.x
- By:
- Publication type:
- Article
Evidence that blood–CSF barrier transport, but not inflammatory biomarkers, change in migraine, while CSF sVCAM1 associates with migraine frequency and CSF fibrinogen.
- Published in:
- Headache: The Journal of Head & Face Pain, 2021, v. 61, n. 3, p. 536, doi. 10.1111/head.14088
- By:
- Publication type:
- Article
Apolipoprotein E controls cerebrovascular integrity via cyclophilin A.
- Published in:
- Nature, 2012, v. 485, n. 7399, p. 512, doi. 10.1038/nature11087
- By:
- Publication type:
- Article
Central role for PICALM in amyloid-β blood-brain barrier transcytosis and clearance.
- Published in:
- Nature Neuroscience, 2015, v. 18, n. 7, p. 978, doi. 10.1038/nn.4025
- By:
- Publication type:
- Article
GLUT1 reductions exacerbate Alzheimer's disease vasculo-neuronal dysfunction and degeneration.
- Published in:
- Nature Neuroscience, 2015, v. 18, n. 4, p. 521, doi. 10.1038/nn.3966
- By:
- Publication type:
- Article
Correction: Blood–brain barrier-associated pericytes internalize and clear aggregated amyloid-β42 by LRP1-dependent apolipoprotein E isoform-specific mechanism.
- Published in:
- 2024
- By:
- Publication type:
- Correction Notice
Anti-malaria drug artesunate prevents development of amyloid-β pathology in mice by upregulating PICALM at the blood-brain barrier.
- Published in:
- Molecular Neurodegeneration, 2023, v. 18, n. 1, p. 1, doi. 10.1186/s13024-023-00597-5
- By:
- Publication type:
- Article
Correction: Anti-malaria drug artesunate prevents development of amyloid-β pathology in mice by upregulating PICALM at the blood-brain barrier.
- Published in:
- 2023
- By:
- Publication type:
- Correction Notice
Anti-malaria drug artesunate prevents development of amyloid-β pathology in mice by upregulating PICALM at the blood-brain barrier.
- Published in:
- Molecular Neurodegeneration, 2023, v. 18, n. 1, p. 1, doi. 10.1186/s13024-023-00597-5
- By:
- Publication type:
- Article
Correction: Blood-brain barrier-associated pericytes internalize and clear aggregated amyloid-β42 by LRP1-dependent apolipoprotein E isoform-specific mechanism.
- Published in:
- 2022
- By:
- Publication type:
- Correction Notice
Blood-brain barrier-associated pericytes internalize and clear aggregated amyloid-β42 by LRP1-dependent apolipoprotein E isoform-specific mechanism.
- Published in:
- Molecular Neurodegeneration, 2018, v. 13, n. 1, p. N.PAG, doi. 10.1186/s13024-018-0286-0
- By:
- Publication type:
- Article